Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing cardiovascular disorders
3.2.1.2 Rising demand for minimally invasive procedures
3.2.1.3 Advancement in healthcare technology
3.2.1.4 Unhealthy and hectic lifestyle
3.2.1.5 Growing geriatric population
3.2.2 Industry pitfalls & challenges
3.2.2.1 Stent failure and recall
3.2.2.2 Stringent regulatory approvals
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Reimbursement scenario
3.6 Technological landscape
3.7 Porter's analysis
3.7.1 Supplier power
3.7.2 Buyer power
3.7.3 Threat of new entrants
3.7.4 Threat of substitutes
3.7.5 Industry rivalry
3.8 PESTEL analysis
3.9 Future market trends
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2018 – 2032 ($ Mn and Units)
5.1 Key trends
5.2 Vascular stents
5.2.1 Coronary stents
5.2.1.1 Bare metal stents
5.2.1.2 Drug eluting stents
5.2.1.3 Bioresorbable stents
5.2.2 Peripheral stents
5.2.2.1 Iliac
5.2.2.2 Femoral-Popliteal
5.2.2.3 Renal
5.2.2.4 Carotid
5.2.3 Neurovascular stents
5.3 Non-vascular stents
Chapter 6 Market Estimates and Forecast, By Material, 2018 – 2032 ($ Mn and Units)
6.1 Key trends
6.2 Metal
6.3 Polymer
Chapter 7 Market Estimates and Forecast, By Type, 2018 – 2032 ($ Mn and Units)
7.1 Key trends
7.2 Self expandable
7.3 Balloon expandable
Chapter 8 Market Estimates and Forecast, By End-Use, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospitals
8.3 Ambulatory surgical centers
8.4 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn and Units)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 Singapore
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 Middle East and Africa
9.6.1 Saudi Arabia
9.6.2 South Africa
9.6.3 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Abbott Laboratories
10.2 B. Braun Melsungen AG
10.3 Biosensors International Group
10.4 Biotronik SE & Co. KG
10.5 Boston Scientific Corporation
10.6 Becton, Dickinson and Company
10.7 Elixir Medical Corporation
10.8 Medtronic Plc
10.9 Meril Life Science
10.10 MicroPort Scientific Corporation
10.11 Stryker Corporation
10.12 Terumo Corporation
10.13 Veryan Medical Limited
10.14 W.L Gore & Associates
